Gene · 27074
Papers3,205
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,205
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The characteristics of cerebrospinal fluid tumor microenvironment in a patient with leptomeningeal metastases from cancer of unknown primary. | Genes Dis | 2024 | 38274387 | PubTator, text mining | PubMed |
Comprehensive analysis revealed the immunoinflammatory targets of rheumatoid arthritis based on intestinal flora, miRNA, transcription factors, and RNA-binding proteins databases, GSEA and GSVA pathway observations, and immunoinfiltration typing. | Hereditas | 2024 | 38273392 | PubTator, text mining | PubMed |
| The implications of FASN in immune cell biology and related diseases. | Cell Death Dis | 2024 | 38272906 | PubTator, text mining | PubMed |
| Multi-omics integration reveals a nonlinear signature that precedes progression of lung fibrosis. | Clin Transl Immunology | 2024 | 38269243 | PubTator, text mining | PubMed |
| Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. | Nat Commun | 2024 | 38267413 | PubTator, text mining | PubMed |
| Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment. | Int J Mol Sci | 2024 | 38256019 | PubTator, text mining | PubMed |
| CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders. | Int J Mol Sci | 2024 | 38255842 | PubTator, text mining | PubMed |
| The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review. | Cancers (Basel) | 2024 | 38254885 | PubTator, text mining | PubMed |
| Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments. | World J Surg Oncol | 2024 | 38254190 | PubTator, text mining | PubMed |
| How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction? | Proteomes | 2024 | 38250815 | PubTator, text mining | PubMed |
| Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix. | Transl Oncol | 2024 | 38242007 | PubTator, text mining | PubMed |
| BTLA biology in cancer: from bench discoveries to clinical potentials. | Biomark Res | 2024 | 38233898 | PubTator, text mining | PubMed |
| Human pluripotent stem cell modeling of alveolar type 2 cell dysfunction caused by ABCA3 mutations. | J Clin Invest | 2024 | 38226623 | PubTator, text mining | PubMed |
| Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. | MedComm (2020) | 2024 | 38222314 | PubTator, text mining | PubMed |
| LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior. | Aging (Albany NY) | 2024 | 38217544 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer. | J Transl Med | 2024 | 38216927 | PubTator, text mining | PubMed |
| Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model. | Cell Death Dis | 2024 | 38195589 | PubTator, text mining | PubMed |
| Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence. | Cell Commun Signal | 2024 | 38195552 | PubTator, text mining | PubMed |
| Unbiased phenotype and genotype matching maximizes gene discovery and diagnostic yield. | Genet Med | 2024 | 38193396 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analyses of tumor microenvironment and molecular reprograming landscape of metastatic laryngeal squamous cell carcinoma. | Commun Biol | 2024 | 38191598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27074/papers?page=15